Aluna, the award-winning lung health management platform, today announced it has completed a $15.3 million Series B round of financing to continue growing its solution among doctors and patients managing asthma, cystic fibrosis and COPD.
There may be hope on the horizon for men who want to have more agency over birth control: YCT-529, a drug candidate that aims to be the first non-hormonal contraceptive pill for men.
